Synthesis and biological evaluation of 5-substituted O4-alkylpyrimidines as CDK2 inhibitors
- 18 March 2010
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 8 (10) , 2397-2407
Abstract
CDK2 inhibitory structure–activity relationships have been explored for a range of 5-substituted O4-alkylpyrimidines. Variation of the 5-substituent in the 2,6-diaminopyrimidine series confirmed the 5-nitroso substituent as optimal, and showed that 5-formyl and 5-acetyl substituents were also tolerated at this position. A series of O4-alkyl-N2-aryl-5-substituted-6-aminopyrimidines revealed interesting structure–activity relationships. In the 5-nitroso series, the optimum O4-alkyl substituents were cyclohexylmethyl or sec-butyl, combined with a 2-sulfanilyl group. By contrast, in the N2-arylsulfonamido-5-formyl series, the cyclohexylmethyl compound showed relatively poor activity compared with the sec-butyl derivative (22j, (R)-4-(4-amino-6-sec-butoxy-5-formylpyrimidin-2-ylamino)benzenesulfonamide; CDK2 IC50 = 0.8 nM). Similarly, in the N2-arylsulfonamido-5-(hydroxyiminomethyl) series the O4-sec-butyl substituent conferred greater potency than the cyclohexylmethyl (23c, (rac)-4-(4-amino-6-sec-butoxy-5-(hydroxyiminomethyl)pyrimidin-2-ylamino)benzenesulfonamide; CDK2 IC50 = 7.4 nM). The 5-formyl derivatives show selectivity for CDK2 over other CDK family members, and are growth inhibitory in tumour cells (e.g.22j, GI50 = 0.57 μM).Keywords
This publication has 20 references indexed in Scilit:
- Cell cycle kinases as therapeutic targets for cancerNature Reviews Drug Discovery, 2009
- Cell cycle, CDKs and cancer: a changing paradigmNature Reviews Cancer, 2009
- Cyclin-dependent kinases and cell-cycle transitions: does one fit all?Nature Reviews Molecular Cell Biology, 2008
- Structure-based design of 2-arylamino-4-cyclohexylmethoxy-5-nitroso-6-aminopyrimidine inhibitors of cyclin-dependent kinase 2Organic & Biomolecular Chemistry, 2007
- N2-Substituted O6-Cyclohexylmethylguanine Derivatives: Potent Inhibitors of Cyclin-Dependent Kinases 1 and 2Journal of Medicinal Chemistry, 2004
- Structure-based design of a potent purine-based cyclin-dependent kinase inhibitorNature Structural & Molecular Biology, 2002
- The Hallmarks of CancerCell, 2000
- Distinct Roles for Cyclin-Dependent Kinases in Cell Cycle ControlScience, 1993
- Regulation of the cell cycle by the cdk2 protein kinase in cultured human fibroblasts.Journal of Cell Biology, 1993
- Pyrimidinones. 1. 2-Amino-5-halo-6-aryl-4(3H)-pyrimidinones. Interferon-inducing antiviral agentsJournal of Medicinal Chemistry, 1985